Labiana Health SA
F:8RK
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
L
|
Labiana Health SA
F:8RK
|
ES |
|
G
|
GS Chain PLC
F:K85
|
UK |
|
E
|
Estre Ambiental Inc
OTC:ESTRF
|
BR |
Intrinsic Value
The intrinsic value of Labiana Health SA (8RK) under the Base Case is 9.14 EUR per share. Compared with the current market price of 4.64 EUR, the stock appears Undervalued by 49% .
The intrinsic value is calculated using valuation multiples.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What Labiana Health Does
Labiana Health is a Spanish pharmaceutical company that makes medicines for both animals and people. Its business covers the development, manufacturing, and sale of finished medicines, with a strong focus on veterinary products such as treatments for pets and livestock, plus a smaller human health line. It also has industrial capabilities to produce medicines for other companies under contract, which adds a manufacturing-services side to the business.
- Headquarters
- Spain ES
- Employees
- 477
- IPO date
- Jun 24, 2022
Earnings Waterfall
Labiana Health SA
The intrinsic value for Labiana Health SA (8RK) under the Base Case is 9.14 EUR.
Compared with the current market price of 4.64 EUR, the stock appears Undervalued by 49% .